Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp

Journal of the American Academy of Dermatology

Volumn 73, Issue 5, 2015, Pages 799-801

  Tauber, Gil ^a   Pavlovsky, Lev ^a   Fenig, Eyal ^a,b   Hodak, Emmilia ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

basal cell carcinoma; Hedgehog; radiotherapy; skin cancer; tinea capitis; vismodegib

Indexed keywords

PREDNISONE; VISMODEGIB; ANILIDE; ANTINEOPLASTIC AGENT; PYRIDINE DERIVATIVE;

ADULT; AGED; ALOPECIA; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSGEUSIA; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MUSCLE SPASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION EXPOSURE; RADIATION INJURY; RASH; REMISSION; SCALP BASAL CELL CARCINOMA; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TINEA CAPITIS; TREATMENT DURATION; TREATMENT RESPONSE; VERY ELDERLY; CARCINOMA, BASAL CELL; HEAD AND NECK NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, RADIATION-INDUCED; SCALP; SKIN NEOPLASMS;

AGED; AGED, 80 AND OVER; ANILIDES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, RADIATION-INDUCED; PYRIDINES; SCALP; SKIN NEOPLASMS;

EID: 84944353589     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.07.016     Document Type: Article

References (5)

1. M.R. Karagas, J.A. McDonald, E.R. Greenberg, and et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy J Natl Cancer Inst 88 24 1996 1848 1853
2. A. Tessone, N. Amariglio, O. Weissman, and et al. Radiotherapy-induced basal cell carcinomas of the scalp: are they genetically different? Aesth Plast Surg 36 2012 1387 1392
3. A. Sekulic, M.R. Migden, A. Oro, and et al. Efficacy and safety of the Hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma (BCC): 12-month ERIVANCE BCC study update Ann Oncol 23 Suppl. 9 2012 ix361 ix375
4. C. Saintes, M. Saint-Jean, A. Brocard, and et al. Development of squamous cell carcinoma into basal cell carcinoma under treatment with vismodegib J Eur Acad Dermatol Venereol 29 5 2015 1006 1009
5. G.A. Zhu, A.S. Li, A.L. Chang, and et al. Patient with Gorlin syndrome and metastatic basal cell carcinoma refractory to smoothened inhibitors JAMA Dermatol 150 8 2014 877 879